Cargando…
A Bilayer Vaginal Tablet for the Localized Delivery of Disulfiram and 5-Fluorouracil to the Cervix
This study was performed to develop an adjuvant therapy in the form of a self-administered vaginal tablet regimen for the localized delivery of chemotherapeutic drugs. This therapy will help to reduce relapse by eradicating cancerous cells in the margin of cervical tumors. The vaginal tablet is a ve...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762309/ https://www.ncbi.nlm.nih.gov/pubmed/33291349 http://dx.doi.org/10.3390/pharmaceutics12121185 |
_version_ | 1783627774730174464 |
---|---|
author | Abidin, Ismin Zainol Rezoagli, Emanuele Simonassi-Paiva, Bianca Fehrenbach, Gustavo Waltzer Masterson, Kevin Pogue, Robert Cao, Zhi Rowan, Neil Murphy, Emma J. Major, Ian |
author_facet | Abidin, Ismin Zainol Rezoagli, Emanuele Simonassi-Paiva, Bianca Fehrenbach, Gustavo Waltzer Masterson, Kevin Pogue, Robert Cao, Zhi Rowan, Neil Murphy, Emma J. Major, Ian |
author_sort | Abidin, Ismin Zainol |
collection | PubMed |
description | This study was performed to develop an adjuvant therapy in the form of a self-administered vaginal tablet regimen for the localized delivery of chemotherapeutic drugs. This therapy will help to reduce relapse by eradicating cancerous cells in the margin of cervical tumors. The vaginal tablet is a very common formulation that is easy to manufacture, easy to place in the vagina, and has a low cost of manufacture, making them ideal for use in developing countries. A combination of disulfiram and 5-fluorouracil, which are both off-patent drugs and provide different modes of action, were evaluated. The tablets developed were evaluated for weight variation, thickness, hardness, friability, swelling index, differential scanning calorimetry (DSC), particle morphology, in vitro drug release, and cytotoxicity on Ca-Ski cells. Both layers were designed to release both drugs concurrently for a synergistic effect. The polymer–polymer interaction between the layers was able to reduce the loss of formulation due to chitosan. While the bilayer tablet had satisfactory performance in the physicochemical tests, in vitro cell culture with Ca-Ski also showed a synergistic effect using a combination of drugs at a low dose. However, the formulation only had 24-h dose release before degradation. Further drug combinations should be evaluated in subsequent studies. |
format | Online Article Text |
id | pubmed-7762309 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77623092020-12-26 A Bilayer Vaginal Tablet for the Localized Delivery of Disulfiram and 5-Fluorouracil to the Cervix Abidin, Ismin Zainol Rezoagli, Emanuele Simonassi-Paiva, Bianca Fehrenbach, Gustavo Waltzer Masterson, Kevin Pogue, Robert Cao, Zhi Rowan, Neil Murphy, Emma J. Major, Ian Pharmaceutics Article This study was performed to develop an adjuvant therapy in the form of a self-administered vaginal tablet regimen for the localized delivery of chemotherapeutic drugs. This therapy will help to reduce relapse by eradicating cancerous cells in the margin of cervical tumors. The vaginal tablet is a very common formulation that is easy to manufacture, easy to place in the vagina, and has a low cost of manufacture, making them ideal for use in developing countries. A combination of disulfiram and 5-fluorouracil, which are both off-patent drugs and provide different modes of action, were evaluated. The tablets developed were evaluated for weight variation, thickness, hardness, friability, swelling index, differential scanning calorimetry (DSC), particle morphology, in vitro drug release, and cytotoxicity on Ca-Ski cells. Both layers were designed to release both drugs concurrently for a synergistic effect. The polymer–polymer interaction between the layers was able to reduce the loss of formulation due to chitosan. While the bilayer tablet had satisfactory performance in the physicochemical tests, in vitro cell culture with Ca-Ski also showed a synergistic effect using a combination of drugs at a low dose. However, the formulation only had 24-h dose release before degradation. Further drug combinations should be evaluated in subsequent studies. MDPI 2020-12-06 /pmc/articles/PMC7762309/ /pubmed/33291349 http://dx.doi.org/10.3390/pharmaceutics12121185 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Abidin, Ismin Zainol Rezoagli, Emanuele Simonassi-Paiva, Bianca Fehrenbach, Gustavo Waltzer Masterson, Kevin Pogue, Robert Cao, Zhi Rowan, Neil Murphy, Emma J. Major, Ian A Bilayer Vaginal Tablet for the Localized Delivery of Disulfiram and 5-Fluorouracil to the Cervix |
title | A Bilayer Vaginal Tablet for the Localized Delivery of Disulfiram and 5-Fluorouracil to the Cervix |
title_full | A Bilayer Vaginal Tablet for the Localized Delivery of Disulfiram and 5-Fluorouracil to the Cervix |
title_fullStr | A Bilayer Vaginal Tablet for the Localized Delivery of Disulfiram and 5-Fluorouracil to the Cervix |
title_full_unstemmed | A Bilayer Vaginal Tablet for the Localized Delivery of Disulfiram and 5-Fluorouracil to the Cervix |
title_short | A Bilayer Vaginal Tablet for the Localized Delivery of Disulfiram and 5-Fluorouracil to the Cervix |
title_sort | bilayer vaginal tablet for the localized delivery of disulfiram and 5-fluorouracil to the cervix |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762309/ https://www.ncbi.nlm.nih.gov/pubmed/33291349 http://dx.doi.org/10.3390/pharmaceutics12121185 |
work_keys_str_mv | AT abidinisminzainol abilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT rezoagliemanuele abilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT simonassipaivabianca abilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT fehrenbachgustavowaltzer abilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT mastersonkevin abilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT poguerobert abilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT caozhi abilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT rowanneil abilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT murphyemmaj abilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT majorian abilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT abidinisminzainol bilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT rezoagliemanuele bilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT simonassipaivabianca bilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT fehrenbachgustavowaltzer bilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT mastersonkevin bilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT poguerobert bilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT caozhi bilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT rowanneil bilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT murphyemmaj bilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix AT majorian bilayervaginaltabletforthelocalizeddeliveryofdisulfiramand5fluorouraciltothecervix |